Predictive Modeling for Treatment of Upper Airway Obstruction in Young Children
Data Collection
Collected from today forward - ProspectiveCongenital Abnormalities+9
+ Jaw Abnormalities
+ Jaw Diseases
Cohort
Tracking disease incidence in order to identify risk factors and understand disease progression over time.Summary
Study start date: April 1, 2011
Actual date on which the first participant was enrolled.The investigators hypothesize that a functional computational model that simulates the mechanical and aerodynamic behavior of the upper airway in children with Pierre Robin Sequence (PRS) and laryngeal lesions (e.g. subglottic stenosis or SGS) can be used as an effective diagnostic and treatment planning tool.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.39 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Cohort
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Until 17 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Inclusion Criteria: Micrognathia, Suspected or Diagnosis of PRS, defined (Gorlin) as: micrognathia (mandibular hypoplasia), cleft palate and airway obstruction, and/or Diagnosis of SGS defined (Bluestone) as: subglottic airway diameter of 4 mm or less in a term neonate; subglottic airway diameter of 3.5 mm or less in a premature neonate; inability to pass an endotracheal tube of expected size for age Informed consent by parent or legal guardian Age < 18 years at enrollment Scheduled for clinically indicated endoscopic upper airway evaluation Ability to comply with study visits and study procedures as judged by the site investigator Inclusion criterion also included for Specific Aim 2 (Longitudinal): Subjects must be scheduled for an operative procedure to correct or bypass upper airway obstruction (i.e. mandibular distraction, endoscopic airway surgery, laryngotracheoplasty, cricotracheal resection, or tracheostomy) OR recently (within past 4 weeks) diagnosed as having an anomaly not currently requiring surgical management. Exclusion Criteria: Acute, intercurrent respiratory infection, defined as an increase from baseline in cough, wheezing, or respiratory rate with onset in the preceding week. Physical findings at screening that would compromise the safety of the participant or the quality of the study (i.e. fever, increased respiratory rate above baseline, significant acute emesis, or alteration in baseline neurologic status). For research CT scans any sedation risk, such as Bronchopulmonary Dysplasia (BPD) with upper airway obstruction, residual oxygen requirement, and an unsecured airway. Control data will be collected from clinically indicated neck or maxillofacial CT imaging data that include the entire airway with no noted airway obstructions or airway abnormalities.
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.3 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
North Carolina Children's Hospital
Chapel Hill, United StatesOpen North Carolina Children's Hospital in Google Maps